These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 6268131

  • 1. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
    Brunner DB, Desponds G, Biollaz J, Keller I, Ferber F, Gavras H, Brunner HR, Schelling JL.
    Br J Clin Pharmacol; 1981 May; 11(5):461-7. PubMed ID: 6268131
    [Abstract] [Full Text] [Related]

  • 2. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
    Biollaz J, Schelling JL, Jacot Des Combes B, Brunner DB, Desponds G, Brunner HR, Ulm EH, Hichens M, Gomez HJ.
    Br J Clin Pharmacol; 1982 Sep; 14(3):363-8. PubMed ID: 6289859
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H.
    J Cardiovasc Pharmacol; 1982 Sep; 4(6):966-72. PubMed ID: 6185790
    [Abstract] [Full Text] [Related]

  • 4. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
    Schiffrin EL, Gutkowska J, Thibault G, Genest J.
    Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602
    [Abstract] [Full Text] [Related]

  • 5. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN, Campbell BC, Reid JL.
    J Cardiovasc Pharmacol; 1982 Jan; 4(3):381-7. PubMed ID: 6177933
    [Abstract] [Full Text] [Related]

  • 6. Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.
    Hansen EF, Bendtsen F, Henriksen JH.
    Pharmacol Toxicol; 1999 Mar; 84(3):110-4. PubMed ID: 10193670
    [Abstract] [Full Text] [Related]

  • 7. The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers.
    Bussien JP, Nussberger J, Porchet M, Waeber B, Brunner HR, Perisic M, Tansey MJ, Bomm M, Hajdu P.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Mar; 329(1):63-9. PubMed ID: 2987705
    [Abstract] [Full Text] [Related]

  • 8. Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.
    MacGregor GA, Markandu ND, Bayliss J, Roulston JE, Squires M, Morton JJ.
    Br Med J (Clin Res Ed); 1981 Aug 08; 283(6288):401-3. PubMed ID: 6266576
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B, Cubela R, Johnston CI.
    J Hypertens; 1984 Aug 08; 2(4):371-7. PubMed ID: 6099390
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. 1981.
    Brunner DB, Desponds G, Biollaz J, Keller I, Ferber F, Gavras H, Brunner HR, Schelling JL.
    Br J Clin Pharmacol; 2004 Dec 08; 58(7):S778-84; discussion S785-7. PubMed ID: 15595971
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The present molecules of converting enzyme inhibitors.
    Brunner HR, Nussberger J, Waeber B.
    J Cardiovasc Pharmacol; 1985 Dec 08; 7 Suppl 1():S2-11. PubMed ID: 2580170
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.